What is the role of praziquantel in the treatment of acute schistosomiasis (Katayama syndrome)?

Updated: Sep 20, 2018
  • Author: Shadab Hussain Ahmed, MD, AAHIVS, FACP, FIDSA; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

The drug of choice for treating all species of schistosomes is praziquantel. Cure rates of 65-90% have been described after a single treatment with praziquantel. In individuals not cured, the drug causes egg excretion to be reduced by 90%. [55] Praziquantel affects the membrane permeability of the parasite, which causes vacuolation of the tegument. It paralyses the worm and exposes it to attack by the host immune system. However, as praziquantel is ineffective on developing schistosomula, it may not abort early infection. Praziquantel can be used in pregnant and lactating women. [56] Resistance to praziquantel occurs in the field and is well defined. [57, 58] Adverse effects include dizziness, headache, nausea, vomiting, diarrhea, abdominal discomfort, bloody stool, urticaria, and fever following initiation of treatment. These are usually mild and last about 24 hours. These are reactions from dying worms.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!